Benzonatate Capsule
Product Images NDC 72789-231

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 72789-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789231 Label (72789231)

This is the label of Benzonatate capsules with dosage information, storage instructions, and manufacturer details. It is advised to keep the capsules away from light and at a controlled room temperature. Consumers are warned to call a doctor regarding any side effects and not to chew or crush the capsules as it may cause drowsiness. The packaging should be kept away from children. The capsules are manufactured by Humanwell PuraCap Pharmaceutical in China and packaged by PD-Rx Pharmaceuticals in Oklahoma.*

FDA Label Image

Structure Formula (Structure Formula)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.